Aghemo A - Search Results

1

New horizons in hepatitis C antiviral therapy with direct-acting antivirals.

Aghemo A, De Francesco R. Aghemo A, et al. Hepatology. 2013 Jul;58(1):428-38. doi: 10.1002/hep.26371. Epub 2013 May 31. Hepatology. 2013. PMID: 23467911 Free article. Review.

2

The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies.

Monti V, Aghemo A, Rumi MG, Donato MF, Del Ninno E, Colombo M. Monti V, et al. Among authors: aghemo a. Antivir Ther. 2005;10(6):715-20. Antivir Ther. 2005. PMID: 16218170 Clinical Trial.

3

Impaired response to interferon-alpha2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infection.

Aghemo A, Rumi MG, Soffredini R, D'Ambrosio R, Ronchi G, Del Ninno E, Gallus S, Colombo M. Aghemo A, et al. Antivir Ther. 2006;11(6):797-802. Antivir Ther. 2006. PMID: 17310824

4

Lack of rapid virological response predicts interferon-alpha2b/ribavirin therapy failure in HCV genotype 2 patients: a single-centre study.

Rumi MG, Aghemo A, D'Ambrosio R, Ronchi G, Del Ninno E, Gallus S, Colombo M. Rumi MG, et al. Among authors: aghemo a. Antivir Ther. 2007;12(7):1033-40. Antivir Ther. 2007. PMID: 18018761

5

The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotype.

Aghemo A, Rumi MG, Monico S, Prati GM, D'Ambrosio R, Donato MF, Colombo M. Aghemo A, et al. Antivir Ther. 2009;14(4):577-84. Antivir Ther. 2009. PMID: 19578243 Clinical Trial.

6

Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C.

Rumi MG, Aghemo A, Prati GM, D'Ambrosio R, Donato MF, Soffredini R, Del Ninno E, Russo A, Colombo M. Rumi MG, et al. Among authors: aghemo a. Gastroenterology. 2010 Jan;138(1):108-15. doi: 10.1053/j.gastro.2009.08.071. Epub 2009 Sep 18. Gastroenterology. 2010. PMID: 19766645 Clinical Trial.

7

Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C.

Aghemo A, Rumi MG, Colombo M. Aghemo A, et al. Expert Rev Anti Infect Ther. 2009 Oct;7(8):925-35. doi: 10.1586/eri.09.70. Expert Rev Anti Infect Ther. 2009. PMID: 19803700 Review.

8

The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirin.

Viganò M, Aghemo A, Iavarone M, Rumi MG, Agnelli F, Lampertico P, Donato MF, Colombo M. Viganò M, et al. Among authors: aghemo a. Antivir Ther. 2009;14(6):789-96. doi: 10.3851/IMP1284. Antivir Ther. 2009. PMID: 19812441

9

Pegylated interferons alpha2a and alpha2b in the treatment of chronic hepatitis C.

Aghemo A, Rumi MG, Colombo M. Aghemo A, et al. Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):485-94. doi: 10.1038/nrgastro.2010.101. Epub 2010 Jul 20. Nat Rev Gastroenterol Hepatol. 2010. PMID: 20644567 Review.

10

Interferon in the treatment of chronic hepatitis C: a drug caught between past and future.

Vezali E, Aghemo A, Colombo M. Vezali E, et al. Among authors: aghemo a. Expert Opin Biol Ther. 2011 Mar;11(3):301-13. doi: 10.1517/14712598.2011.552906. Epub 2011 Jan 21. Expert Opin Biol Ther. 2011. PMID: 21250869 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters